Your browser doesn't support javascript.
loading
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
Cabrera-Serrano, Antonio José; Sánchez-Maldonado, José Manuel; Ter Horst, Rob; Macauda, Angelica; García-Martín, Paloma; Benavente, Yolanda; Landi, Stefano; Clay-Gilmour, Alyssa; Niazi, Yasmeen; Espinet, Blanca; Rodríguez-Sevilla, Juan José; Pérez, Eva María; Maffei, Rossana; Blanco, Gonzalo; Giaccherini, Matteo; Cerhan, James R; Marasca, Roberto; López-Nevot, Miguel Ángel; Chen-Liang, Tzu; Thomsen, Hauke; Gámez, Irene; Campa, Daniele; Moreno, Víctor; de Sanjosé, Silvia; Marcos-Gragera, Rafael; García-Álvarez, María; Dierssen-Sotos, Trinidad; Jerez, Andrés; Butrym, Aleksandra; Norman, Aaron D; Luppi, Mario; Slager, Susan L; Hemminki, Kari; Li, Yang; Berndt, Sonja I; Casabonne, Delphine; Alcoceba, Miguel; Puiggros, Anna; Netea, Mihai G; Försti, Asta; Canzian, Federico; Sainz, Juan.
Afiliación
  • Cabrera-Serrano AJ; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, 18016 Granada, Spain.
  • Sánchez-Maldonado JM; Instituto de Investigación Biosanitaria IBs.Granada, 18012 Granada, Spain.
  • Ter Horst R; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, 18016 Granada, Spain.
  • Macauda A; Instituto de Investigación Biosanitaria IBs.Granada, 18012 Granada, Spain.
  • García-Martín P; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Benavente Y; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Landi S; Hospital Campus de la Salud, PTS, 18016 Granada, Spain.
  • Clay-Gilmour A; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.
  • Niazi Y; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain.
  • Espinet B; CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
  • Rodríguez-Sevilla JJ; Department of Biology, University of Pisa, 56126 Pisa, Italy.
  • Pérez EM; Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Greenville, SC 29208, USA.
  • Maffei R; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
  • Blanco G; Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.
  • Giaccherini M; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.
  • Cerhan JR; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
  • Marasca R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • López-Nevot MÁ; Hospital Campus de la Salud, PTS, 18016 Granada, Spain.
  • Chen-Liang T; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, 41124 Modena, Italy.
  • Thomsen H; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.
  • Gámez I; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
  • Campa D; Department of Biology, University of Pisa, 56126 Pisa, Italy.
  • Moreno V; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
  • de Sanjosé S; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, 41124 Modena, Italy.
  • Marcos-Gragera R; Immunology Department, Virgen de las Nieves University Hospital, 18014 Granada, Spain.
  • García-Álvarez M; Hematology Department, Morales Meseguer University Hospital, 30008 Murcia, Spain.
  • Dierssen-Sotos T; MSB Medical School Berlin, D-14197 Berlin, Germany.
  • Jerez A; Hematology Department, Morales Meseguer University Hospital, 30008 Murcia, Spain.
  • Butrym A; Department of Biology, University of Pisa, 56126 Pisa, Italy.
  • Norman AD; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.
  • Luppi M; Cancer Prevention and Control Program, Unit of Biomarkers and Susceptibility, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology, 08907 Barcelona, Spain.
  • Slager SL; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, 08907 Barcelona, Spain.
  • Hemminki K; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.
  • Li Y; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain.
  • Berndt SI; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain.
  • Casabonne D; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona Biomedical Research Institute (IdiBGi), 17190 Girona, Spain.
  • Alcoceba M; Department of Nursing, Universitat de Girona, 17007 Girona, Spain.
  • Puiggros A; Josep Carreras Leukemia Research Institute, 08916 Girona, Spain.
  • Netea MG; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • Försti A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain.
  • Canzian F; Faculty of Medicine, University of Cantabria, 39011 Santander, Spain.
  • Sainz J; Department of Hematology, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, 08035 Barcelona, Spain.
Int J Mol Sci ; 24(9)2023 Apr 28.
Article en En | MEDLINE | ID: mdl-37175717
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: España